
HCA Healthcare (HCA) Stock Forecast & Price Target
HCA Healthcare (HCA) Analyst Ratings
Bulls say
HCA Healthcare's strong financial outlook is bolstered by its status as the largest integrated healthcare delivery system in the United States, providing unmatched scale and infrastructure. The company anticipates growth in the fourth quarter, driven by year-over-year contributions from Mission Health, which is expected to surpass the impacts of prior disruptions. Additionally, the approval of the TN program is anticipated to positively affect third-quarter earnings, further enhancing the company's financial position.
Bears say
HCA Healthcare faces significant headwinds, including a projected 5% decline in earnings estimates for 2026, alongside an anticipated contraction in its valuation multiple to 8.0x. This negative outlook is further compounded by management's expectation of a decrease of approximately $130 million in DPP contributions year-over-year in the second half, primarily due to the comparative performance in the fourth quarter. Additionally, the recent adjustment of the enterprise multiple to 9.25x from 9.5x underscores concerns regarding EBITDA growth sustainability moving forward.
This aggregate rating is based on analysts' research of HCA Healthcare and is not a guaranteed prediction by Public.com or investment advice.
HCA Healthcare (HCA) Analyst Forecast & Price Prediction
Start investing in HCA Healthcare (HCA)
Order type
Buy in
Order amount
Est. shares
0 shares